NCT04517682View on ClinicalTrials.gov

COVID-19 and SARS-CoV-2 Detection in Saliva

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

May 21, 2020

Primary Completion Date

March 16, 2021

Study Completion Date

August 5, 2021

Conditions
RNA Virus Infections
Interventions
DIAGNOSTIC_TEST

RT-PCR

The RT-PCR assay will be performed on paired nasopharyngeal and saliva samples

Trial Locations (1)

92656

Ambry Genetics, Aliso Viejo

Sponsors

Lead Sponsor

Ambry Genetics
All Listed Sponsors
collaborator

The Saratoga Hospital

UNKNOWN

collaborator

St. Joseph Hospital of Orange

OTHER

collaborator

Crozer-Keystone Health System

OTHER

lead

Ambry Genetics

INDUSTRY

NCT04517682 - COVID-19 and SARS-CoV-2 Detection in Saliva | Biotech Hunter | Biotech Hunter